Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04925492 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04925492 · ClinicalTrials.gov record · last posted 2026-08-18

PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD

StatusCompleted
PhasePhase 1
Started2022-11-11
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The purpose of this study is to find objective biomarkers of vaso-occlusion (blood vessel blockage) in people with SCD. Using information from earlier studies and work being done, researchers have developed a strategy to image VOC, using positron emission tomography (PET). The ability to see and measure VOC in SCD patients can help patient care, by showing when and how a VOC is occurring or going to occur. Studying this method will also help in future drug research, as it will allow researchers to deliver promising new medications that target hyper-adhesion and sickling in people with SCD.

Protocol amendment history 4 changes detected by DataLookout

2026-08-19
notable
Trial completed
2026-08-19
notable
Enrollment reduced: 20 → 15 participants
2026-08-19
minor
Primary completion moved earlier: 2026-12-31 → 2026-03-11
2026-08-19
minor
Completion moved earlier: 2027-12-31 → 2026-03-31
Trial Details
NCT Number NCT04925492
Lead Sponsor Enrico Novelli
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Sickle Cell Disease
Enrollment 15 participants
Start Date 2022-11-11
Primary Completion 2026-03-11 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-18